LifeScience Clinical & Diagnostic

Thermo Fisher's Two-Day Turnaround Chromosomal Microarray Boosts Lab Productivity

Thermo Fisher Scientific, the world leader in serving science,  announced the launch of a new chromosomal microarray designed to improve cytogenetic r...

 August 23, 2023 | News

Paradigm Therapeutics Acquires Breakthrough Therapy for EB Treatment

Paradigm Therapeutics Inc., a biopharmaceutical company,  announced the completion of the acquisition of the worldwide rights of SD-101, a topical who...

 August 23, 2023 | News

MGI Partners with NGeneBio to Advance Precision Medicine

This strategic partnership will enable the integration of NGeneBio's advanced diagnostic assays with MGI's high-throughput sequencing technology to acceler...

 August 23, 2023 | News

Mammotome Unveils HydroMARK™ Plus: Innovative Breast Biopsy Site Marker

"I am excited for this innovative biopsy marker to come to market," said Radiologist Dr. Evita Singh, Director of Breast Imaging at Karmanos Cancer In...

 August 22, 2023 | News

Hummingbird Bioscience to Present HMBD-001 Combo Strategy for Lung Cancer at 2023 Conference

The poster will highlight the scientific rationale for combining anti-HER3 antibody HMBD-001 with EGFR inhibition and chemotherapy to improve treatment out...

 August 22, 2023 | News

Everest Medicines' Partner Calliditas Therapeutics Gets FDA Priority Review for Nefecon® in IgA Nephropathy

"We congratulate our partner Calliditas for being granted priority review by the FDA for full approval and taking a step closer to offering this first-in-d...

 August 22, 2023 | Regulatory

Satio Partners with BARDA DRIVe for Patch-Based Ebola Diagnostic

This groundbreaking diagnostic will combine Satio's patch-based blood collection device with Institut Pasteur de Dakar's sensitive and rapid...

 August 21, 2023 | News

Innovent's SINTBILO® Receives NMPA Approval for Treating Hypercholesterolemia

The prevalence of cardiovascular diseases is continuously increasing in China, among which atherosclerotic cardiovascular disease (ASCVD) is the leadi...

 August 17, 2023 | News

FDA Grants Priority Review for Cefepime-Taniborbactam to Treat cUTI

Everest Medicines (HKEX 1952.HK)'s partner Venatorx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted the company's N...

 August 16, 2023 | News

OnCusp Therapeutics Gets FDA Nod for Phase 1 Trial of CUSP06 in Ovarian & Solid Tumors

"We are delighted to announce the IND approval for our flagship program, CUSP06, which has demonstrated excellent anti-tumor efficacy across diverse in&nbs...

 August 16, 2023 | News

TB Alliance and Remington Pharma Partner to Launch New Therapy for Drug-Resistant TB in Pakistan

Non-profit drug developer TB Alliance has granted Remington Pharmaceutical Industries (Pvt.) Ltd. a non-royalty bearing license to market the anti-tubercul...

 August 15, 2023 | News

Sunbird Bio Joins Glympse Bio to Advance Protein-Based Diagnostics

 Combined company will operate as Sunbird Bio and focus on advancing clinical-stage platforms with demonstrated potential to enhance patient care in A...

 August 14, 2023 | News

Asieris Reports Successful Phase III Bridging Trial for Hexvix® in Bladder Cancer Diagnosis

The study is a prospective, self-controlled, multicenter Phase Ⅲ trial aimed at investigating the additional detection rate and safety of Hexvix®&nbs...

 August 14, 2023 | News

Mindray & Operation Smile Launch 10-Year Partnership to Enhance Healthcare for Vulnerable Communities

As a globally trusted innovator in medical devices and solutions, Mindray brings cutting-edge technology and medical expertise to the collaboration. Throug...

 August 09, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close